
Sign up to save your podcasts
Or


Governments worldwide are intensifying their focus on compliance in financial institutions, particularly in Know Your Customer and Anti-Money Laundering efforts. This episode explores the challenges of detecting Trade-Based Money Laundering and the role of artificial intelligence in combating this issue. It also provides an update on recent legislative developments addressing cross-border financial crimes, including Trade-Based Money Laundering.
Read the full article.
About the authors
Howard W. Herndon
Robert A. Broadbent
In this episode, we delve deep into the realm of bankruptcy law and the issues faced by suppliers when shipping goods to financially distressed customers.
Read the full article.
About the author
Edward L. Schnitzer
As a firm, we believe our team members unique perspectives allow us to deliver more integrated solutions, fresh perspectives, and quality advice. Each Saturday throughout the month, we're broadcasting interviews with some of our attorneys featuring stories about their careers and told in their own words, illustrating just how our firm offers a point of view like no other. First up, Jed Nosel from Boston.
Read more about Jed.
Tender offers may seem like they're exclusive to publicly listed businesses, but they actually play a crucial role in private company dealings too. These offers serve as a bridge connecting aspiring investors, or even the company itself, to shareholders. They allow for an increase in stake or a reduction in outstanding options. However, it's important to conduct these offers within the rules and regulations set by the U.S. Securities and Exchange Commission (SEC). So, get ready as we explore the intriguing question of when a transaction qualifies as a tender offer and the potential regulatory implications it carries for private companies.
Read the full article.
About the authors:
D. Scott Anderson
Patrick T. Strubbe
Jake G. Rifkin
Aerospace, defense, and security businesses are subject to a myriad of regulations and operational requirements that are constantly changing. In this episode, we'll dig into some of these changes and discuss what they mean as we look ahead to 2024 and beyond.
Read the full article.
About the authors:
Richard J.R. Raleigh, Jr.
Christopher L. Lockwood
In this episode, we explore the evolving landscape of technology-based information-gathering, navigating the key differences between tasking an individual source and asking a crowd. We unpack how the shift from traditional HUMINT collection to crowdsourcing has been made possible by technological advancements, and discuss the importance of implementing an enhanced safeguard framework for responsible data usage.
Read the full article
About the authors
Robert A. Broadbent
Howard W. Herndon
On January 10, 2024, the United States Patent and Trademark Office (USPTO) published Guidelines, applicable to any technology, for ascertaining compliance with the enablement requirement in view of the U.S. Supreme Court decision in Amgen v. Sanofi (“Amgen”). According to the Guidelines, which will be incorporated into the Manual of Patent Examining Procedure in due course, the USPTO will continue to use the In re Wands (“Wands”) factors when determining whether claims in a patent application are enabled. The USPTO considers that its current policies on enablement are consistent with Amgen and post-Amgen enablement decisions from the Federal Circuit.
Read the full article.
About the authors
Seiko Okada, M.D., Ph.D.
Julie Broadus Meigs, Ph.D.
This month, the Consumer Financial Protection Bureau (CFPB) started the new year by filing an amicus brief in an ongoing appeal in the First Circuit focusing on an interpretation of the Fair Debt Collection Practices Act (FDCPA), specifically 1692e. While FDCPA litigators await a decision on this issue, debt collectors can use this case as a reminder to understand how their technologies, like bankruptcy scrubs and letter logic, can prevent litigation like this case.
Read the full article.
About the author
Justin T. Bradley
Following the lead of other states, Missouri recently introduced its own version of Commercial Finance Disclosure Law legislation. With a similar law introduced last session, how does this new legislation differ from prior bills?
Read the full article.
About the authors
Joel L. Perrell Jr.
Eryn Brasovan
Many who suffer from nasal and sinus congestion are familiar with pseudoephedrine and it’s shift from a simple purchase to one requiring a pharmacist consult and proper photo identification.
After this change, the industry pivoted to phenylephrine as a substitute for pseudoephedrine to ensure the continued availability of over-the-counter decongestants. Fast forward to now, when the FDA has recently released a briefing document on oral phenylephrine use, and whether it’s as effective as first thought.
Read the full article.
About the authors
Jonathon A. Fligg
Madeline Campbell, Ph.D.*
From the publisher's feed
Welcome to Womble Perspectives, where we explore a wide range of topics from the latest legal updates to industry trends to the business of law. Our team of lawyers, professionals and occasional…